For prostate cancer survivors, clinical trials may offer another path when standard treatments stop working or are no longer the best choice. These studies test new ways to slow cancer growth, manage side effects, or improve care. Some focus on lowering hormones that help prostate cancer grow. Others aim to weaken cancer cells by blocking their ability to repair damage.
Clinical trial participation is a personal decision and may not be right for everyone. Join us for this month’s fireside chat with a representative from Telix Pharmaceuticals to learn why clinical trials matter and how they may open the door to new treatment options.
“Clinical trials are part of your treatment options, and I encourage you to participate when applicable and available.” -Keith Crawford, MD, PhD
At the end of this session, attendees will:
- Better understand prostate cancer clinical trials and their purpose
- Explain how clinical trials can be considered part of treatment options
- Learn how new clinical trials may help stop or slow the spread of prostate cancer
Agenda:
Discuss Clinical Trials and Review the Find Your Trial (FYT) Tool: Dr. Crawford will provide an overview of clinical trials and review the Find Your Trial (FYT) tool.
Understand the Importance of Participating in Clinical Trials: Dr. Crawford will discuss with the representative from Telix Pharmaceuticals the benefits of clinical trials as treatment options.
Clinical Trial Highlight: Dr. Crawford will provide an overview of the Merck Omaha-003, Omaha-004, and AstraZeneca EvoPAR-PR02 clinical trials.
Survivor Man-to-Man Session: An informal discussion among prostate cancer survivors attending the in-person meeting at Dana-Farber Cancer Institute.
Registration: https://us02web.zoom.us/webinar/register/9817703186941/WN_tQHrEPaGQFCqKTtlNHIgRA